Evidence map›Paper›PMID 26902152›Full record

ArticleScientific reports2016

Regulation of Transcription Factor Yin Yang 1 by SET7/9-mediated Lysine Methylation.

Wen-juan Zhang, Xiao-nan Wu, Tao-tao Shi, Huan-teng Xu, Jia Yi, Hai-feng Shen, Ming-feng Huang, Xing-yi Shu, Fei-fei Wang, Bing-ling Peng and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Yin Yang 1: Function, Mechanisms, and Glia.Neurochemical research · 2025
    Review
  3. Article
  4. Determining the Substrate Specificity of Lysine Methyltransferases.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  5. Lysine and arginine methylation of transcription factors.Cellular and molecular life sciences : CMLS · 2024
    Review
  6. Article
  7. Article
  8. Targeting the PHF8/YY1 axis suppresses cancer cell growth through modulation of ROS.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Activation of Young LINE-1 Elements by CRISPRa.International journal of molecular sciences · 2023
    Article
  11. Review
  12. iScience · 2023
    Article
  13. Review
  14. [Research Progress of Role and Mechanism of SETD7 in Tumor Occurrence 
and Progression].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2023
    Article
  15. Article
  16. Dual Role of YY1 in HPV Life Cycle and Cervical Cancer Development.International journal of molecular sciences · 2022
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Wen-juan ZhangSchool of Pharmaceutical Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
Xiao-nan WuSchool of Pharmaceutical Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
Tao-tao ShiSchool of Pharmaceutical Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
Huan-teng XuSchool of Pharmaceutical Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
Jia YiSchool of Pharmaceutical Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
Hai-feng ShenSchool of Pharmaceutical Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
Ming-feng HuangSchool of Pharmaceutical Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
Xing-yi ShuSchool of Pharmaceutical Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
Fei-fei WangSchool of Pharmaceutical Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
Bing-ling PengSchool of Pharmaceutical Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
Rong-quan XiaoSchool of Pharmaceutical Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
Wei-wei GaoSchool of Pharmaceutical Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
Jian-cheng DingSchool of Pharmaceutical Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
Wen LiuSchool of Pharmaceutical Sciences, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Yin Yang 1 (YY1) is a multifunctional transcription factor shown to be critical in a variety of biological processes. Although it is regulated by multiple types of post-translational modifications (PTMs), whether YY1 is methylated, which enzyme methylates YY1, and hence the functional significance of YY1 methylation remains completely unknown. Here we reported the first methyltransferase, SET7/9 (KMT7), capable of methylating YY1 at two highly conserved lysine (K) residues, K173 and K411, located in two distinct domains, one in the central glycine-rich region and the other in the very carboxyl-terminus. Functional studies revealed that SET7/9-mediated YY1 methylation regulated YY1 DNA-binding activity both in vitro and at specific genomic loci in cultured cells. Consistently, SET7/9-mediated YY1 methylation was shown to involve in YY1-regulated gene transcription and cell proliferation. Our findings revealed a novel regulatory strategy, methylation by lysine methyltransferase, imposed on YY1 protein, and linked YY1 methylation with its biological functions.

Indexed as

Protein Processing, Post-TranslationalTranscription, GeneticCell ProliferationCRISPR-Cas SystemsHEK293 CellsHeLa CellsHistone-Lysine N-MethyltransferaseHumansLysineMethylationPlasmidsProtein DomainsRecombinant ProteinsRNA, Small InterferingTransfectionYY1 Transcription FactorHistone-Lysine N-MethyltransferaseLysineRecombinant ProteinsRNA, Small InterferingSETD7 protein, humanYY1 protein, humanYY1 Transcription Factor

Identifiers

PMID26902152
PMCPMC4763200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.